Reduced Dicer expression in the cord blood of infants admitted with severe respiratory syncytial virus disease

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Inchley, Christopher S ^a   Sonerud, Tonje ^a   Fjærli, Hans O ^a   Nakstad, Britt ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; RNA; RIBONUCLEASE III;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; RESPIRATORY SYNCYTIAL VIRUS INFECTION; UMBILICAL CORD BLOOD; ADULT; BIOSYNTHESIS; ENZYMOLOGY; FETUS BLOOD; GENE EXPRESSION PROFILING; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROARRAY ANALYSIS; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIROLOGY;

ADULT; CHILD, PRESCHOOL; FEMALE; FETAL BLOOD; GENE EXPRESSION PROFILING; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROARRAY ANALYSIS; NASOPHARYNX; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RIBONUCLEASE III;

EID: 79952339372     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-59     Document Type: Article

References (47)

1. Kim HW, Arrobio JO, Brandt CD, Jeffries BC, Pyles G, Reid JL, Chanock RM, Parrott RH. Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol 1973, 98:216-225.
2. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999, 282:1440-1446. 10.1001/jama.282.15.1440, 10535434.
3. Nokes DJ, Okiro EA, Ngama M, Ochola R, White LJ, Scott PD, English M, Cane PA, Medley GF. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis 2008, 46:50-57. 10.1086/524019, 2358944, 18171213.
4. Mufson MA, Levine HD, Wasil RE, Mocega-Gonzalez HE, Krause HE. Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am J Epidemiol 1973, 98:88-95.
5. Karron RA, Singleton RJ, Bulkow L, Parkinson A, Kruse D, DeSmet I, Indorf C, Petersen KM, Leombruno D, Hurlburt D, et al. Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group. J Infect Dis 1999, 180:41-49. 10.1086/314841, 10353859.
6. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986, 140:543-546.
7. Brandt CD, Kim HW, Arrobio JO, Jeffries BC, Wood SC, Chanock RM, Parrott RH. Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics. Am J Epidemiol 1973, 98:355-364.
8. Fjaerli HO, Farstad T, Rod G, Ufert GK, Gulbrandsen P, Nakstad B. Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway. BMC Pediatr 2005, 5:31. 10.1186/1471-2431-5-31, 1199604, 16109158.
9. Fjaerli HO, Farstad T, Bratlid D. Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study. BMC Pediatr 2004, 4:25. 10.1186/1471-2431-4-25, 544884, 15606912.
10. Leader S, Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 2002, 21:629-632. 10.1097/00006454-200207000-00005, 12237593.
11. Amanatidou V, Apostolakis S, Spandidos DA. Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection. Pediatr Infect Dis J 2009, 28:135-140. 10.1097/INF.0b013e31818c8d17, 19106772.
12. Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 2008, 82:2040-2055. 10.1128/JVI.01625-07, 2258918, 17928346.
13. Forton JT, Rowlands K, Rockett K, Hanchard N, Herbert M, Kwiatkowski DP, Hull J. Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster. Thorax 2009, 64:345-352. 10.1136/thx.2008.102111, 3015100, 19131452.
14. Janssen R, Bont L, Siezen CL, Hodemaekers HM, Ermers MJ, Doornbos G, van't Slot R, Wijmenga C, Goeman JJ, Kimpen JL, et al. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis 2007, 196:826-834. 10.1086/520886, 17703412.
15. Siezen CL, Bont L, Hodemaekers HM, Ermers MJ, Doornbos G, Van't Slot R, Wijmenga C, Houwelingen HC, Kimpen JL, Kimman TG, et al. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Pediatr Infect Dis J 2009, 28:333-335. 10.1097/INF.0b013e31818e2aa9, 19258923.
16. Power UF. Respiratory syncytial virus (RSV) vaccines--Two steps back for one leap forward. Journal of Clinical Virology 2008, 41:38-44. 10.1016/j.jcv.2007.10.024, 18340669.
17. Oshansky CM, Zhang W, Moore E, Tripp RA. The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiology 2009, 4:279-297. 10.2217/fmb.09.1, 2711508, 19327115.
18. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
19. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007, 6:443-453. 10.1038/nrd2310, 17541417.
20. Muller S, Imler JL. Dicing with viruses: microRNAs as antiviral factors. Immunity 2007, 27:1-3. 10.1016/j.immuni.2007.07.003, 17663977.
21. Matskevich AA, Moelling K. Dicer is involved in protection against influenza A virus infection. J Gen Virol 2007, 88:2627-2635. 10.1099/vir.0.83103-0, 17872512.
22. Aliyari R, Ding SW. RNA-based viral immunity initiated by the Dicer family of host immune receptors. Immunol Rev 2009, 227:176-188. 10.1111/j.1600-065X.2008.00722.x, 2676720, 19120484.
23. DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, Walsh E, Meyers R, Gollob J, Vaishnaw A. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci USA 2010, 107:8800-8805. 10.1073/pnas.0912186107, 2889365, 20421463.
24. Alvarez R, Elbashir S, Borland T, Toudjarska I, Hadwiger P, John M, Roehl I, Morskaya SS, Martinello R, Kahn J, et al. RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother 2009, 53:3952-3962. 10.1128/AAC.00014-09, 2737834, 19506055.
25. Fjaerli HO, Bukholm G, Skjaeret C, Holden M, Nakstad B. Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis. J Infect Dis 2007, 196:394-404. 10.1086/519168, 17597454.
26. Olsen MA, Shuck KM, Sambol AR. Evaluation of Abbott TestPack RSV for the diagnosis of respiratory syncytial virus infections. Diagn Microbiol Infect Dis 1993, 16:105-109. 10.1016/0732-8893(93)90003-P, 8467621.
27. Kehl SC, Henrickson KJ, Hua W, Fan J. Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J Clin Microbiol 2001, 39:1696-1701. 10.1128/JCM.39.5.1696-1701.2001, 88011, 11325976.
28. Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med 2000, 154:55-61.
29. Fixler DE. Respiratory syncytial virus infection in children with congenital heart disease: a review. Pediatr Cardiol 1996, 17:163-168. 10.1007/BF02505206, 8662029.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
31. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, et al. The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clinical Chemistry 2009, 55:611-622. 10.1373/clinchem.2008.112797, 19246619.
32. GenBank. , http://www.ncbi.nlm.nih.gov/genbank/index.html
33. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010, 10:111-122.
34. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008, 359:2641-2650. 10.1056/NEJMoa0803785, 2710981, 19092150.
35. Wu JF, Shen W, Liu NZ, Zeng GL, Yang M, Zuo GQ, Gan XN, Ren H, Tang KF. Down-regulation of Dicer in hepatocellular carcinoma. Med Oncol 2010,
36. Grelier G, Voirin N, Ay AS, Cox DG, Chabaud S, Treilleux I, Leon-Goddard S, Rimokh R, Mikaelian I, Venoux C, et al. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 2009, 101:673-683. 10.1038/sj.bjc.6605193, 2736830, 19672267.
37. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005, 202:261-269. 10.1084/jem.20050678, 2212998, 16009718.
38. Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG, Merkenschlager M. A role for Dicer in immune regulation. J Exp Med 2006, 203:2519-2527. 10.1084/jem.20061692, 2118134, 17060477.
39. Fedeli M, Napolitano A, Wong MP, Marcais A, de Lalla C, Colucci F, Merkenschlager M, Dellabona P, Casorati G. Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol 2009, 183:2506-2512. 10.4049/jimmunol.0901361, 19625646.
40. Kuipers H, Schnorfeil FM, Fehling HJ, Bartels H, Brocker T. Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo. J Immunol 2010, 185:400-409. 10.4049/jimmunol.0903912, 20530258.
41. Krishnan S, Halonen M, Welliver RC. Innate immune responses in respiratory syncytial virus infections. Viral Immunol 2004, 17:220-233. 10.1089/0882824041310612, 15279701.
42. Webb TJ, Sumpter TL, Thiele AT, Swanson KA, Wilkes DS. The phenotype and function of lung dendritic cells. Crit Rev Immunol 2005, 25:465-491.
43. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009, 8:129-138. 10.1038/nrd2742, 19180106.
44. Huang DD. The potential of RNA interference-based therapies for viral infections. Curr HIV/AIDS Rep 2008, 5:33-39. 10.1007/s11904-008-0006-4, 18417033.
45. Deffrasnes C, Cavanagh MH, Goyette N, Cui K, Ge Q, Seth S, Templin MV, Quay SC, Johnson PH, Boivin G. Inhibition of human metapneumovirus replication by small interfering RNA. Antivir Ther 2008, 13:821-832.
46. Zamora MR, Budev M, Rolfe M, Gottlieb J, Humar A, Devincenzo J, Vaishnaw A, Cehelsky J, Albert G, Nochur S, et al. RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med 2010, 183:531-538. 10.1164/rccm.201003-0422OC, 20851929.
47. Wiesen JL, Tomasi TB. Dicer is regulated by cellular stresses and interferons. Mol Immunol 2009, 46:1222-1228. 10.1016/j.molimm.2008.11.012, 2678889, 19118902.